COMP <GO>
ACU vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
Acme United Corporation. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: ACU 5
— PG 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: ACU
LAST: $67.26 (-1.25%) • MKT CAP: $261.1M
balance-sheet
5.72
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACU VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACU | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.40% | 51.20% | -11.80 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 25.40% | -16.20 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.3x | 16.2x | -4.90 | ACU | /valuation <GO> |
| Free Cash Flow Yield | 2.90% | 3.77% | -0.87 | PG | /fcf-yield <GO> |
| Operating Margin | 7.50% | 24.30% | -16.80 | PG | /operating-margins <GO> |
| Net Profit Margin | 5.20% | 19.00% | -13.80 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 0.30% | +0.80 | ACU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.90% | 2.65% | -1.75 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 5.72 | 5.59 | +0.13 | ACU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ACU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.7 | 60.3 | +9.40 | ACU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 21.7x | +2.10 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $261.1M | $372.21B | -$371.95B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACU REV | PG REV | ACU GROSS % | PG GROSS % | ACU FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $196.5M | $84.28B | 39.4% | 51.2% | $7.6M | $14.04B |
| FY 2024 | $194.5M | $84.04B | 39.3% | 51.4% | $4.8M | $16.52B |
| FY 2023 | $191.5M | $82.01B | — | — | $28.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACU // BETA —
PG // BETA 0.87